
Sexual health has changed dramatically over the past decade. Today, we have medications that can significantly reduce the risk of HIV — and, for some people, several common bacterial sexually transmitted infections (STIs).
Two prevention strategies you may be hearing more about are PrEP and DoxyPEP. They sound similar, but they do very different things: PrEP helps prevent HIV, while DoxyPEP can reduce the risk of syphilis, chlamydia, and, to a lesser degree, gonorrhea in certain people.
What Is PrEP?
PrEP stands for pre-exposure prophylaxis. It is medication taken by a person who does not have HIV to substantially reduce the chance of acquiring HIV through sex or injection drug use.
The CDC recommends that healthcare providers inform sexually active adults and adolescents about PrEP and prescribe it to people who request it, even when they do not report specific HIV risk factors. Options include daily oral medications and long-acting injectable options.
Before starting PrEP, HIV testing is needed to confirm that you do not already have HIV. Depending on the medication selected, kidney function and hepatitis B screening may also be appropriate. People taking PrEP continue regular HIV and STI screening and routine follow-up.
What Is DoxyPEP?
DoxyPEP stands for doxycycline post-exposure prophylaxis. Instead of taking medication before an exposure, DoxyPEP involves taking the antibiotic doxycycline after sex to reduce the likelihood of acquiring certain bacterial STIs.
Current CDC guidance recommends discussing DoxyPEP with gay, bisexual, and other men who have sex with men and transgender women who have been diagnosed with syphilis, chlamydia, or gonorrhea within the previous 12 months. For people outside these groups, the available evidence is more limited, so treatment decisions need to be individualized.
When prescribed
The CDC-recommended regimen is doxycycline 200 mg as soon as possible after oral, vaginal/front-hole, or anal sex — ideally within 24 hours and no later than 72 hours afterward. It should not be taken more than once every 24 hours, with a maximum of 200 mg in that period.
How Effective Is DoxyPEP?
In studies involving gay and bisexual men and transgender women at increased STI risk, DoxyPEP reduced syphilis and chlamydia infections by more than 70% and reduced gonorrhea infections by approximately 50% overall. Effectiveness against gonorrhea is less consistent because some strains are resistant to tetracycline antibiotics.
DoxyPEP reduces risk — it does not eliminate it.
PrEP and DoxyPEP Work Differently
This distinction is important: PrEP is for HIV prevention, while DoxyPEP is for bacterial STI prevention. DoxyPEP does not prevent HIV, and PrEP does not prevent syphilis, gonorrhea, or chlamydia.
Neither medication eliminates the need for routine STI testing. For an appropriate patient, however, PrEP and DoxyPEP can potentially be used together as part of a broader sexual-health strategy.
Taking DoxyPEP Safely
Doxycycline is generally well tolerated, but it can cause nausea, stomach upset, diarrhea, irritation of the esophagus, and increased sensitivity to sunlight.
Take it with food and at least 8 ounces of water. Remain upright for at least one hour afterward, because taking doxycycline immediately before bed can increase the risk of esophageal irritation or injury.
Calcium, iron, magnesium supplements, antacids, and dairy products can interfere with absorption and should generally be separated from the medication according to your healthcare provider’s instructions. Sun protection is also important.
What About Antibiotic Resistance?
Unlike PrEP, DoxyPEP involves taking an antibiotic repeatedly. Researchers continue to study how widespread use could affect antibiotic resistance — not only among STIs such as gonorrhea, but potentially among other bacteria normally carried by the body.
That does not mean DoxyPEP should not be used. It means it should be prescribed thoughtfully, for people most likely to benefit, with periodic reassessment of whether it is still appropriate.
Regular Testing Still Matters
Preventive medication does not replace sexual-health screening. People using DoxyPEP should generally undergo STI testing at the sites where exposure occurs, which can include urine/urethral, throat, and rectal testing in addition to blood testing for syphilis.
CDC guidance recommends bacterial STI testing at baseline and approximately every 3–6 months for people using DoxyPEP. People taking PrEP also need regular HIV testing and follow-up appropriate to the PrEP medication they are using. Routine screening matters because many STIs cause no symptoms at all.
What If You Think You Were Just Exposed to HIV?
PrEP and HIV PEP are different. If you are not taking PrEP and believe you may have recently been exposed to HIV, do not wait for symptoms or your next routine appointment.
HIV post-exposure prophylaxis (PEP) can prevent HIV after a potential exposure, but it needs to be started within 72 hours — and the sooner it is started, the better. A possible HIV exposure should be treated as a time-sensitive medical issue.
Sexual Health Without Judgment
Talking about sexual health should be no different from talking about blood pressure, cholesterol, or vaccinations. Your healthcare provider needs accurate information about your sexual activity — not to judge you, but to determine which tests, medications, vaccines, and prevention strategies may actually benefit you.
That conversation might include PrEP for HIV prevention, DoxyPEP for bacterial STI prevention when appropriate, routine HIV and STI screening, hepatitis A and B vaccination, HPV vaccination when indicated, condoms, contraception, and other individualized strategies.
Interested in PrEP or DoxyPEP?
DDC Health provides confidential, judgment-free sexual-health care, including HIV and STI screening and individualized discussions about PrEP and DoxyPEP. If you’d like to know whether one — or both — might be appropriate for you, schedule an appointment with DDC Health.
This article is for educational purposes and does not replace individualized medical advice. PrEP and DoxyPEP require evaluation and prescription by a qualified healthcare professional.
Back to journal